Cindy L. Evans

1.1k total citations
16 papers, 813 citations indexed

About

Cindy L. Evans is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Cindy L. Evans has authored 16 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Cindy L. Evans's work include Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Cindy L. Evans is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Cindy L. Evans collaborates with scholars based in United States, Austria and United Kingdom. Cindy L. Evans's co-authors include Harry G. Rittenhouse, Stephen D. Mikolajczyk, Harry J. Linton, William J. Catàlona, Lisa S. Millar, Helmut Klocker, Wolfgang Horninger, Kathy M. Marker, Georg Bartsch and Janice K. Payne and has published in prestigious journals such as The Journal of Urology, International Journal of Radiation Oncology*Biology*Physics and Clinical Chemistry.

In The Last Decade

Cindy L. Evans

15 papers receiving 777 citations

Peers

Cindy L. Evans
Per-Anders Abrahamsson Sweden
Brigitte Brux Germany
Gordon O’Neill Australia
M. Cheung United States
Chris Bangma Netherlands
Phataraporn Thorson United States
Egils Vjaters Latvia
Xavier Maldonado Spain
Rachel E. Carlson United States
Nina-Sophie Schmidt-Hegemann Germany
Per-Anders Abrahamsson Sweden
Cindy L. Evans
Citations per year, relative to Cindy L. Evans Cindy L. Evans (= 1×) peers Per-Anders Abrahamsson

Countries citing papers authored by Cindy L. Evans

Since Specialization
Citations

This map shows the geographic impact of Cindy L. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cindy L. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cindy L. Evans more than expected).

Fields of papers citing papers by Cindy L. Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cindy L. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cindy L. Evans. The network helps show where Cindy L. Evans may publish in the future.

Co-authorship network of co-authors of Cindy L. Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Cindy L. Evans. A scholar is included among the top collaborators of Cindy L. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cindy L. Evans. Cindy L. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Cullen, Valerie, et al.. (2012). Development and Advanced Validation of an Optimized Method for the Quantitation of Aβ42 in Human Cerebrospinal Fluid. The AAPS Journal. 14(3). 510–518. 31 indexed citations
3.
McLaughlin, William P., et al.. (2009). Vessel Sparing Radiotherapy for Prostate Cancer: Clinical Results with a Minimum of 2-year Follow-up. International Journal of Radiation Oncology*Biology*Physics. 75(3). S12–S12. 1 indexed citations
4.
Khan, Masood A., Lori J. Sokoll, Daniel W. Chan, et al.. (2004). Clinical utility of proPSA and “benign” PSA when percent free PSA is less than 15%. Urology. 64(6). 1160–1164. 37 indexed citations
5.
Mikolajczyk, Stephen D., William J. Catàlona, Cindy L. Evans, et al.. (2004). Proenzyme Forms of Prostate-Specific Antigen in Serum Improve the Detection of Prostate Cancer. Clinical Chemistry. 50(6). 1017–1025. 117 indexed citations
6.
Catàlona, William J., Georg Bartsch, Harry G. Rittenhouse, et al.. (2004). SERUM PRO-PROSTATE SPECIFIC ANTIGEN PREFERENTIALLY DETECTS AGGRESSIVE PROSTATE CANCERS IN MEN WITH 2 TO 4 NG/ML PROSTATE SPECIFIC ANTIGEN. The Journal of Urology. 171(6 Part 1). 2239–2244. 116 indexed citations
7.
Catàlona, William J., Georg Bartsch, Harry G. Rittenhouse, et al.. (2003). Serum Pro Prostate Specific Antigen Improves Cancer Detection Compared to Free and Complexed Prostate Specific Antigen in Men With Prostate Specific Antigen 2 to 4 Ng/Ml. The Journal of Urology. 170(6). 2181–2185. 119 indexed citations
8.
Sokoll, Lori J., Daniel W. Chan, Stephen D. Mikolajczyk, et al.. (2003). Proenzyme psa for the early detection of prostate cancer in the 2.5–4.0 ng/ml total psa range: preliminary analysis. Urology. 61(2). 274–276. 92 indexed citations
9.
Cochlin, D.Ll. & Cindy L. Evans. (2001). Uroradiology: Imaging in Prostate Cancer. Clinical Radiology. 56(11). 871–872.
10.
Finlay, Judith A., John Day, Cindy L. Evans, et al.. (2001). Development of a Dual Monoclonal Antibody Immunoassay for Total Human Kallikrein 2. Clinical Chemistry. 47(7). 1218–1224. 18 indexed citations
11.
Mikolajczyk, S D, Kathy M. Marker, Lisa S. Millar, et al.. (2001). A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer.. PubMed. 61(18). 6958–63. 156 indexed citations
12.
Kumar, Abhay, Janice K. Payne, Cindy L. Evans, et al.. (1999). Large-Scale Propagation of Recombinant Adherent Cells That Secrete a Stable Form of Human Glandular Kallikrein, hK2. Protein Expression and Purification. 15(1). 62–68. 6 indexed citations
13.
14.
Pannek, Jürgen, Harry G. Rittenhouse, Cindy L. Evans, et al.. (1997). Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer. Urology. 50(5). 715–721. 33 indexed citations
15.
Lyons, K., P.N. Matthews, & Cindy L. Evans. (1988). Lesson of the Week: Obstructive uropathy without dilatation: a potential diagnostic pitfall. BMJ. 296(6635). 1517–1518. 16 indexed citations
16.
Evans, Cindy L.. (1981). A review of non-Hodgkin's lymphomata of the head and neck.. PubMed. 7(1). 23–31. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Per-Anders Abrahamsson Breakdown of academic impact, for papers by Brigitte Brux Breakdown of academic impact, for papers by Gordon O’Neill Breakdown of academic impact, for papers by M. Cheung Breakdown of academic impact, for papers by Chris Bangma Breakdown of academic impact, for papers by Phataraporn Thorson Breakdown of academic impact, for papers by Egils Vjaters Breakdown of academic impact, for papers by Xavier Maldonado Breakdown of academic impact, for papers by Rachel E. Carlson Breakdown of academic impact, for papers by Nina-Sophie Schmidt-Hegemann
Rankless by CCL
2026